8-KOther EventsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Corporate Update (Oct 28, 2022)

Filed October 28, 2022For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on October 27, 2022, to report on the issuance of a substantial aggregate principal amount of senior notes. On October 25, 2022, the company entered into underwriting and pricing agreements with a syndicate of underwriters, led by BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, U.S. Bancorp Investments, Inc., and Wells Fargo Securities, LLC. This filing details the sale of seven distinct series of notes with varying interest rates and maturity dates, ranging from October 15, 2024, to February 15, 2063. The issuance is part of the company's ongoing debt financing activities and was completed on October 28, 2022, under the terms of an existing indenture and subsequent officers' certificates and company orders. The notes were registered under a previously filed automatic shelf registration statement on Form S-3. This filing serves primarily to disclose the agreements and legal documentation associated with this significant debt offering, providing transparency to investors regarding the company's capital structure and financing arrangements.

Key Highlights

  • 1UnitedHealth Group (UNH) issued multiple series of senior notes with a total aggregate principal amount of $9,000,000,000.
  • 2The notes have varying interest rates and maturity dates, ranging from October 2024 to February 2063.
  • 3The issuance was conducted under an Underwriting Agreement and Pricing Agreement dated October 25, 2022.
  • 4Key underwriters involved include BofA Securities, Barclays Capital, Citigroup Global Markets, J.P. Morgan Securities, U.S. Bancorp Investments, and Wells Fargo Securities.
  • 5The notes were issued on October 28, 2022, pursuant to an existing Indenture dated February 4, 2008.
  • 6This debt offering was registered under UNH's automatic shelf registration statement on Form S-3.
  • 7The filing includes various exhibits such as the underwriting agreement, pricing agreement, officers' certificates, company orders, and legal opinions related to the notes.

Frequently Asked Questions